Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies

Abstract

Background and Objectives: Movement disorders are underrecognized in the developmental and epileptic encephalopathies (DEEs). There are now over 800 genes implicated in causing the DEEs; relatively few of these rare genetic diseases are known to be associated with movement disorders. We identified patients with genetic DEEs who had movement disorders, classified the nature of their movement disorders and asked whether specific patterns correlated with the underlying mechanism. Methods: We classified the type of movement disorders associated with specific genetic DEEs in a large international cohort of patients and analysed whether specific patterns of movement disorders reflected the underlying biological dysfunction. Results: Our cohort comprised 77 patients with a genetic DEE with a median age of 9 (range 1-38) years. Stereotypies (37/77, 48%) and dystonia (34/77, 44%) were the most frequent movement disorders, followed by chorea (18/77, 23%), myoclonus (14/77, 18%), ataxia (9/77, 12%), tremor (7/77, 9%) and hypokinesia (6/77, 8%). In 47% of patients, a combination of movement disorders was seen. The movement disorders were first observed at a median age of 18 months (range day 2 - 35 years). Dystonia was more likely to be observed in non-ambulatory patients, while ataxia was less likely. In 46% of patients, therapy was initiated with medication (34/77, 44%), DBS (1/77, 1%), or intrathecal baclofen (1/77, 1%). We found that patients with channelopathies or synaptic vesicle trafficking defects were more likely to have dystonia; whereas, stereotypies were most frequent in individuals with transcriptional defects. Discussion: Movement disorders are often underrecognized in patients with genetic DEEs but recognition is critical for the management of these complex neurological diseases. Distinguishing movement disorders from epileptic seizures is important in tailoring patient treatment. Understanding which movement disorders occur with different biological mechsnisms will inform early diagnosis and management.

Corrections to Received Date Information

“…“Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies” by van der Veen et al 18 : Received by Neurology February 17, 2023.…”

“…Due to an error in the Neurology editorial office's content management system, several papers were published with incorrect received date information. The correct received dates, which should have been listed in the Publication History section, are provided for each paper below.“Association Between Hippocampal Volumes and Cognition in Cerebral Amyloid Angiopathy” by Perosa et al 1 : Received by Neurology July 8, 2022.“Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease” by Acha et al 2 : Received by Neurology August 28, 2022.“Association of Glycemic Variability With Imaging Markers of Vascular Burden, β-Amyloid, Brain Atrophy, and Cognitive Impairment” by Jang et al 3 : Received by Neurology January 17, 2023.“Association of Motor Function With Cognitive Trajectories and Structural Brain Differences” by Wang et al 4 : Received by Neurology December 17, 2022.“Association of Neighborhood-Level Socioeconomic Factors With Delay to Hospital Arrival in Patients With Acute Stroke” by Forman et al 5 : Received by Neurology January 10, 2023.“Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS” by Cagol et al 6 : Received by Neurology January 19, 2023.“Clinical Reasoning: A 74-Year-Old Woman Presenting With Monocular Ptosis and Binocular Diplopia” by Liu et al 7 : Received by Neurology November 16, 2022.“Clinical Reasoning: A Woman With Progressive Painless Sequential Monocular Vision Loss” by Ditrapani et al 8 : Received by Neurology August 8, 2022.“Comparison of 2 Methods for Estimating Multiple Sclerosis–Related Mortality” by Rollot et al 9 : Received by Neurology October 20, 2022.“Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study” by Northuis et al 10 : Received by Neurology January 4, 2023.“Effectiveness of Yoga Intervention in Reducing Felt Stigma in Adults With Epilepsy: A Randomized Controlled Trial” by Kaur et al 11 : Received by Neurology October 14, 2022.“[18F]DPA-714 PET Imaging in the Presurgical Evaluation of Patients With Drug-Resistant Focal Epilepsy” by Cheval et al 12 : Received by Neurology November 26, 2022.“Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries” by Krzyzanowski et al 13 : Received by Neurology October 30, 2022.“Interplay Between Chronic Kidney Disease, Hypertension, and Stroke” by Kelly et al 14 : Received by Neurology September 14, 2022.“Measures of Aging Biology in Saliva and Blood as Novel Biomarkers for Stroke and Heart Disease in Older Adults” by Waziry et al 15 : Received by Neurology November 28, 2022.“Molecular and Phenotypic Characterization of the RORB-Related Disorder” by Gokce-Samar et al 16 : Received by Neurology January 5, 2023.“Mortality and Causes of Death in Children With Cerebral Palsy With Scoliosis Treated With and Without Surgery” by Ahonen et al 17 : Received by Neurology February 13, 2023.“Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies” by van der Veen et al 18 : Received by Neurology February 17, 2023.“MRI vs CT for Baseline Im...…”